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Transforming growth factor-β/bone morphogenetic protein (TGF-β/BMP) signaling pathway is essential for embryonic and postnatal heart
development and remodeling. The intracellular factor Smad4 plays a pivotal role in mediating TGF-β/BMP signal transduction in the nucleus. To
examine the function of Smad4 in embryonic cardiac development during mid-gestation, we specifically deleted the Smad4 gene in embryonic
cardiomyocytes using the Cre–LoxP system. Deletion of Smad4 as early as E9.5, led to embryonic lethality between E12.5 and E15.5, and
embryos exhibited severe morphological defects in the heart, including a thin compact layer, disorganized trabeculae, and ventricular septum
defects (VSD). Smad4 deletion also led to a dramatic decrease in cardiomyocyte proliferation accompanied by downregulation of contractile
protein-encoding genes such as α-myosin heavy chain, β-myosin heavy chain, ventricular myosin light chain 2, and α-cardiac actin. In addition,
deletion of Smad4 resulted in perturbation of TGF-β/BMP ligand expression and signaling, and defects in expression of several cardiac
transcription factor genes such as Nkx2.5, GATA4, and MEF2c. These results provide direct genetic evidences that Smad4 is essential for
regulating cardiomyocyte proliferation and differentiation during murine cardiogenesis, and provides new insights into potential causes of
congenital heart disease.
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Heart formation is a complex multiple-stage process that is
composed of a series of precisely regulated molecular and
morphogenetic events, including cardiac cell specification, heart
tube looping, cardiac chamber segmentation and growth, and
cardiac valve formation (Srivastava and Olson, 2000). Through
a complex series of morphogenetic events, the linear primordial
heart tube becomes gradually transformed into a synchronously
contracting four-chambered heart, including atrial and ventri-⁎ Corresponding authors. X. Gao is to be contacted at fax: +86 25 58641500.
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doi:10.1016/j.ydbio.2007.08.022cular chamber myocardium, a conduction system, and physi-
cally separate systemic and pulmonary blood streams (Lamers
and Moorman, 2002). During mid-gestation, ventricular trabe-
culation and compaction are two critical processes that maintain
hemodynamic pressure and support continuing embryonic
development. To correctly achieve these processes, proliferation
and differentiation of cardiomyocytes must be tightly regulated.
Recent studies have revealed multiple signaling pathways
involved in the genetic regulation of ventricular trabeculation,
including Notch (Grego-Bessa et al., 2007), Neuregulin and its
receptor ErbB (Gassmann et al., 1995; Lee et al., 1995; Meyer
and Birchmeier, 1995), vascular endothelial growth Factor
(Ferrara et al., 1996), and bone morphogenetic protein 10
(BMP10) (Chen et al., 2004).
The transforming growth factor-β (TGF-β) superfamily
includes essential regulators of cell fate involved in a wide
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involved in TGF-β/BMP signal transduction have been
shown to be expressed both in the developing and the
adult heart (Pelton et al., 1991; Schlange et al., 2000).
Disruption of many of these genes leads to heart defects. For
example, Bmp2, TGF-β1, and TGF-β2 mutant mice exhibit
myocardial deficiencies in the atrial septum and ventricular
outflow tract, and deficient valve differentiation and cushion
formation (Bartram et al., 2001; Letterio et al., 1994; Ma et
al., 2005; Rivera-Feliciano and Tabin, 2006; Sanford et al.,
1997; Zhang and Bradley, 1996). BMP4 signaling has been
shown to be required for cardiac morphogenesis (Nakajima et
al., 2002; Schlueter et al., 2006; Choi et al., 2007), as well as
outflow-tract septation and branchial-arch artery remodeling
(Liu et al., 2004). Defective trabeculation of the ventricular
myocardium is observed in Bmp10 and Bmp5;Bmp7 double
mutant mice (Chen et al., 2004; Solloway and Robertson,
1999). Deletion of the BMP Receptor IA (ALK3) gene in
neural crest cells leads to embryonic lethality due to
ventricular dysfunction prior to E12.5 (Stottmann et al.,
2004), while cardiomyocyte-specific knockout of ALK3
causes embryonic lethality between E12.5 and E15.5 due to
defective cardiac cushion and myocardium formation (Gaus-
sin et al., 2002). In spite of these important insights,
however, the molecular mechanisms mediating TGF-β signals
during ventricular trabeculation and compaction processes are
still largely unknown.
Studies in other systems have revealed that TGF-β
signaling is transduced through transmembrane serine/threo-
nine kinase receptors and intracellular mediators known as
Smads (Massague et al., 2005). Overexpression of Smad1 or 4
in cardiomyocyte induces differentiation upon stimulation with
BMP (Monzen et al., 2001). In contrast, overexpression of the
inhibitor Smad6 prevents cardiomyocyte differentiation (Gal-
vin et al., 2000). Several pieces of evidence support the notion
that BMP signaling, together with GATA factors, directly
regulates expression of the transcription factor Nkx2.5 via
Smad1/4 (Brown et al., 2004; Lee et al., 2004; Liberatore et
al., 2002; Lien et al., 2002). Previous studies have provided
conflicting results regarding the role of Smads in cardiomyo-
cyte apoptosis. We previously showed that loss of Smad5
results in abnormal heart development and apoptosis of
cardiac myocytes (Sun et al., 2005; Yang et al., 1999),
whereas a recent study showed that Smads can induce
apoptosis in cardiomyocytes (Schneiders et al., 2005). We
previously reported that restricted inactivation of Smad4 in
adult mouse heart results in cardiac hypertrophy and heart
failure (Wang et al., 2005). However, the essential role of
Smad4 in embryonic heart development has not been
elucidated, owing largely to the fact that knockout of the
Smad4 gene in mice leads to early embryonic lethality (Sirard
et al., 1998; Yang et al., 1998). Here, we present the results of
deletion of the Smad4 gene specifically in embryonic
cardiomyocyte and smooth muscle cell using the Cre–LoxP
system with the α-smooth muscle actin (α-SMA)–Cre
transgenic mouse strain (Wu et al., 2007). We show that
embryos lacking Smad4 in cardiomyocytes die between E12.5and E15.5, displaying hypoplasia of ventricles and defects in
ventricle morphogenesis. Our results reveal essential function
for Smad4 in regulating cardiomyocyte proliferation and
differentiation during ventricular development.
Materials and methods
Mouse strains and genotyping
Generation of the Smad4-floxed and α-SMA–Cre mouse strains was
reported previously (Wu et al., 2007; Yang et al., 2002). The genotypes of
live-born animals and embryos were determined by PCR of tail tissue- and yolk
sac-extracted DNA, respectively. For embryos collection, noon of the day that
vaginal plug appeared was considered as 0.5 day post-coitum (dpc). Littermate
embryos were used in all experiments.
X-gal staining
Tissue distribution and excision activity of Cre recombinase was checked by
crossing α-SMA–Cre or α-MHC–Cre transgenic line with ROSA26 reporter
mouse strain (Soriano, 1999). Embryos were collected at E8.5, E9.5, E10.5, and
E11.5, respectively, and stained with X-gal following standard steps to detect β-
galactosidase activity (Yang et al., 2005). Embryos were fixed in 4%
paraformaldehyde (PFA), paraffin-embedded and sectioned (6 μm). The slides
were dewaxed, rehydrated and conterstained with Neutral Fast Red for better
visualization of histology.
Histology and immunohistology
Embryos at different developing stages were harvested by cesarean
section, rinsed with ice-cold phosphate-buffered saline (PBS), pH 7.4, fixed in
4% PFA overnight, paraffin-embedded, sectioned (6 μm), and stained with
hematoxylin and eosin following standard protocol. Immunohistochemistry of
Smad4 (Santa Cruz), phosphorylated Smad2 (P-Smad2, Cell Signaling),
phosphorylated Smad1/5/8 (P-Smad1/5/8, Cell Signaling) and 5-bromo-2-
deoxyuridine (BrdU, Sigma) was performed on 6 μm paraffin sections of
E10.5, E11.5 and E12.5 embryos strictly following the manufacturer's
instructions. Signals were detected by using DAB and hydrogen peroxide.
Slides were counterstained with hematoxylin. For analyzing of proliferative
activity of developing cardiomyocytes, timed-mated females were given a
single injection of 10 mg/ml BrdU (Sigma) 2 h before embryos harvesting
(5 μl/g body weight). Activity of P-Smad2, P-Smad1/5/8 and proliferation
index was calculated by counting relative proportion of P-Smad2, P-Smad1/5/
8 or BrdU-positive to total cells on scanned images from representative
sections. Apoptosis was monitored using a terminal deoxynucleotidyltransfer-
ase-mediated dUTP nick end labeling (TUNEL) assay done on 6 μm paraffin
sections of 4% formalin-fixed specimens using the ApopTag Peroxidase In situ
Apoptosis Detection Kit according to instructions of the manufacturer
(Chemicon).
In situ hybridization
In situ hybridization was done using standard procedures. Briefly, embryos
were fixed in 4% PFA at 4 °C overnight, dehydrated through graded ethanol
and xylene and embedded in paraffin wax. Sections of 6 μm thickness were
cut and treated with proteinase K (20 mg/ml at room temperature for 8 min),
0.2 M HCl for 5 min, and freshly diluted 0.1 M triethanolamine/acetate
anhydride for 10 min. They were hybridized with 35S-UTP-labeled riboprobes
at 50 °C overnight. After hybridization, the slides were treated with 20 mg/ml
of RNase A at 37 °C for 30 min, washed (final washing was 0.1× SSC at
65 °C) and dehydrated through graded ethanol. Slides were dipped in
emulsion (Amersham Pharmacia) and exposed for 5 or 10 days for different
genes before developing. Antisense probes specific for MLC2v, α-Cardiac
actin, α-MHC, β-MHC, Nkx2.5 and ANF were constructed as described
(Miller-Hance et al., 1993; Moens et al., 1993; Tanaka et al., 1999) and
labeled with 35S-labeled UTP using the MAXIscript In vitro Transcription Kit
(Ambion).
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TRIzol reagent (Invitrogen) was used to isolate mRNA from pooled E12.5
embryonic ventricles. First-strand cDNA synthesis was performed using 2 μg of
total RNAwith AMV reverse transcriptase (Takara). Quantitative real-time PCR
was performed using a LightCycler thermal cycler (Roche). Amplification was
carried out as recommended by the manufacturer. Data were normalized by PCR
analysis of Hprt. The amplification program included the initial denaturation
step at 95 °C for 2 min, and 45 cycles of denaturation at 95 °C for 2 s, annealing
at 58 °C for 3 s and extension at 72 °C for 11 s. The temperature transition rate
was 20°C/s. Fluorescence was measured at the end of each extension. Melting
curves were used to determine the specificity of PCR products, which was
further confirmed using conventional gel electrophoresis. For RT–PCR and
quantitative real-time PCR analysis, related primers used to amplify each gene
were listed in Supplementary Table 1. Each experiment was repeated at least
four times with two individual comparable pools of hearts.
Statistics
All results were presented as mean±SEM. All statistical analysis was done
using Excel software. Statistical differences were determined by Student's t test.
⁎Pb0.05; ⁎⁎Pb0.01. Pb0.05 was considered significant.
Results
α-SMA–Cre-mediated recombination in cardiomyocytes at
mid-gestation
We previously reported a transgenic mouse that expresses
Cre recombinase under the control of mouse α-smooth muscle
actin (α-SMA) promoter, leading to efficient expression of Cre
in smooth muscle cells of the lung, trachea, esophagus,
stomach, intestine, uterus, bladder, and blood vessels in adults
(Wu et al., 2007, and data not shown).
To characterize the embryonic expression of this line, we
bred α-SMA–Cre mice with ROSA26 reporter mice (Soriano,
1999). α-SMA–Cre;ROSA26 embryos were harvested at
different embryonic stages to examine LacZ expression. At
E8.5, there was no signal in any part of the embryo including the
heart region (Fig. 1A). Cre-mediated recombination in embryo-
nic hearts was detectable at E9.5 (Fig. 1B). More intense LacZ
expression was detected in hearts of E10.5 α-SMA–Cre;
ROSA26 embryos (Fig. 1C). In contrast, α-MHC–Cre (Wang
et al., 2005) led to weak and punctate LacZ expression in atrium
of E11.5 α-MHC–Cre;ROSA26 embryos (Fig. 1E) compared to
strong and thorough expression in E11.5 α-SMA–Cre;ROSA26
heart (Fig. 1D). Transverse sections of E11.5 α-SMA–Cre;
ROSA26 embryos revealed LacZ expression in all atrial and
ventricular cardiomyocytes (Figs. 1F, H), while no expression
was detected in non-myocyte components of the heart,
including the endocardial layer, the endocardial cushion, and
epicardial cells (Figs. 1F, H). In contrast, comparable sections of
E11.5 α-MHC–Cre;ROSA26 embryos revealed LacZ expres-
sion only in a few cardiomyocytes in atrium (Figs. 1G, I).
Relatively weak LacZ expression was detected in mesenchymal
cells between somites at E10.5 in α-SMA–Cre;ROSA26
embryos (Fig. 1C). LacZ expression was not detected in
vascular smooth muscle cells until E12.5 (Supplementary Figs.
S1A, B). No obvious phenotypes resulted from expression of
the Cre in α-SMA–Cre transgenic mice alone. Together, thesedata suggest that the α-SMA–Cre transgenic mice could be used
to achieve Cre-mediated recombination in cardiomyocytes at
mid-gestation.
Disruption of Smad4 in embryonic cardiomyocytes resulted in
mid-gestational lethality
To assess the necessity of Smad4 for heart development, we
bred mice homozygous for a floxed Smad4 allele (Smad4Co/Co)
with α-SMA–Cre transgenic mice carrying one floxed Smad4
allele (Smad4Co/+;α-SMA–Cre). No viable Smad4Co/Co;α-
SMA–Cre offspring were born, suggesting that they had died
in uterus (Table 1). Timed matings were initiated to obtain
mutant embryos at different developmental stages (Table 1).
Genotyping analysis of E11.5 embryos revealed that 27 of 112
embryos (24.4%) were Smad4Co/Co;α-SMA–Cre (Table 1).
From E12.5 onwards, the number of mutant embryos appeared
with decreasing frequency. A total of 118 embryos of this
genotype were detected among the 799 genotyped embryos
from stages E12.5 to E16.5. Analysis of Smad4 expression at
E11.5 revealed that Smad4 was detected in the trabecular
myocardium and ventricular compact wall of Smad4Co/+;α-
SMA–Cre embryonic hearts (Fig. 1J), but was dramatically
decreased in the Smad4Co/Co;α-SMA–Cre hearts (Fig. 1K).
Excision of exon 8 was confirmed by PCR and RT–PCR
analysis of embryonic hearts (Figs. 1L, M). There was residual
Smad4 in the E10.5 and E11.5 heart, because the expression of
Smad4 in endothelial cells and epicardial cells retained in
Smad4Co/Co;α-SMA–Cre heart (Fig. 1K). Most of the geno-
typed mutant embryos died before E15.5, with a few exceptions
(Fig. 1N).
Next, we carried out morphological analysis of E11.5–E15.5
embryos. At E11.5, all Smad4Co/Co;α-SMA–Cre mutant
embryos appeared normal compared with non-mutant litter-
mates (Figs. 2A, E). At E12.5–13.5, a major part of mutant
embryos could not be distinguished from control littermates, but
some contained enlarged dorsal aortas that appeared to be filled
with blood, in addition to a blood-engorged liver (Figs. 2B, C, F,
G). Almost all mutant embryos recovered at E15.5 were
undergoing resorption (Figs. 2D, H).
Defective ventricular trabecular myocardium and
interventricular septum in Smad4 mutant embryonic hearts
We analyzed serial histological sections of E11.5–14.5
Smad4Co/Co;α-SMA–Cre mutant embryos for ventricular
abnormalities. At E12.5, all the heterozygous control embryos
displayed prominent cardiac trabeculations and a normal
compact zone (Figs. 3A, C). In contrast, 20% Smad4 mutant
hearts exhibited poorly developed trabeculae and a less
structured myocardium including an extremely thin compact
zone (Figs. 3B, D). The interventricular septum in Smad4
mutants was thin and appeared fragile (Fig. 3B). However, no
obvious defect was observed in the outflow tract (Figs. 3E, F)
and atrial–ventricular (AV) cushion (data not shown). At E14.5,
all Smad4Co/Co;α-SMA–Cre hearts displayed obvious ventri-
cular septum defects (VSD) (Fig. 3H). To check whether loss
Fig. 1. Targeted disruption of Smad4 in cardiomyocytes at mid-gestation. (A) Whole-mount X-Gal staining of E8.5 α-SMA–Cre;ROSA26 embryo. No signal was
detected in heart region (boxed). (B) Whole-mount X-Gal staining of E9.5 ROSA26 (left) and α-SMA–Cre;ROSA26 (right) embryos. X-Gal activity was detected only
in the heart of α-SMA–Cre;ROSA26 embryos (arrows). (C) Expression pattern of α-SMA–Cre transgene at E10.5. Arrow shows signal at somites. (D, E) LacZ staining
of E11.5 α-SMA–Cre;ROSA26 (D) and α-MHC–Cre;ROSA26 heart (E), arrow indicates weak signals in atrial myocytes. (F, G) Transverse sections of X-gal-stained
hearts of E11.5 α-SMA–Cre;ROSA26 (F) and α-MHC–Cre;ROSA26 embryos (G), arrowheads indicate atrial signals. (H, I) Higher magnification of X-gal-stained
cardiomyocytes of left ventricles of E11.5 α-SMA–Cre;ROSA26 (H) and α-MHC–Cre;ROSA26 embryos (I), endothelial cells (arrowheads) and epicardial region
(arrow) are negatively stained. All sections were counterstained with Nuclear Fast Red. (J, K) Immunohistochemical staining of Smad4 reveals ubiquitous localization
in cardiomyocytes of E10.5 control heart. (J) and reduced expression specifically in Smad4Co/Co;α-SMA–Cre cardiomyocytes (K), endothelial cells (arrowheads) and
epicardial cells (arrow) give normal signal. (L) PCR analysis of DNA samples extracted from excised hearts or trunks of Smad4Co/Co;α-SMA–Cre embryos at E9.5,
E10.5 and E11.5. (M) RT–PCR analysis of Smad4 expression from Smad4 mutant and control hearts. GAPDH served as internal control. (N) Prevalence of the
Smad4Co/Co;α-SMA–Cre genotype (designated as CKO) in litters at E11.5–E16.5 genotyped by PCR analysis of yolk sacs. RA, right atrium; LA, left atrium; RV, right
ventricle; LV, left ventricle; OFT, outflow tract.
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differentiation which could contribute to the cardiac defects,
we examined α-smooth muscle actin and CD31 immuno-
fluorescence staining to illustrate the maturation of carotidaorta in E12.5 mutant embryos with heart malformation. The
results revealed the normal development of VSMC/pericytes
around the endothelial cells of carotid aorta in Smad4 mutants
(Supplementary Figs. S1C, D).
Table 1
Prevalence of the Smad4Co/Co;α-SMA–Cre genotype and phenotypes in litters





Normal Abnormal Absorbed Total
E11.5 112 0 0 112 27 (24.4%)
E12.5 308 8 2 318 68 (21.4%)
E13.5 149 7 8 164 27 (16.6%)
E14.5 122 3 6 141 13 (9.3%)
E15.5 100 3 2 105 8 (7.6%)
E16.5 70 1 1 71 2 (2.8%)
Newborn 138 0 0 138 0
All embryos, including absorbed embryos, were genotyped using the yolk
sac, and those of genotype Smad4Co/Co;α-SMA–Cre were designated CKO.
Apparently dead embryos with an intact appearance were classified as abnormal.
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embryos
The reduced cell numbers in Smad4 mutant hearts could be
due to reduced proliferation and/or increased apoptosis. To
access whether cardiomyocyte proliferation was affected in the
myocardium lacking Smad4, we examined BrdU incorporation
in E10.5, E11.5, and E12.5 litters. At E10.5, BrdU labeling
showed no difference of proliferation rate between control and
mutant embryos (30.1±2.8% cells positive for BrdU in
controls vs. 30.1±3.2% in mutants, and data not shown).
However, cardiomyocyte proliferation decreased dramatically
at E11.5. In control E11.5 hearts, 33.9% of cells were BrdU-
positive in the interventricular septum and 35.9% of cells were
positive in the ventricular compact wall (n=4 each; Fig. 3O).
While in E11.5 Smad4 mutants, 27.6% of cells were BrdU-Fig. 2. Morphological analysis of Smad4-deficient embryos. (A–H) Gross morpholo
littermates (E–H) at E11.5, E12.5, E13.5 and E15.5. No apparent morphologica
hemorrhage in blood vessel at E12.5 (white arrow in panel F), and in the liver at E1positive in the interventricular septum, and 24.8% were
positive in the ventricular compact wall (n=4 each; Fig. 3O).
Decreased cardiomyocyte proliferation was also observed in
E12.5 Smad4 mutant hearts (BrdU-positive cells in interven-
tricular septum, 31.8% in controls vs. 23.4% in mutants; BrdU-
positive cells in compact wall, 31.9% in controls vs. 21.2% in
mutants; Figs. 3I–L, O).
To examine whether loss of Smad4 affects cardiomyocyte
apoptosis, E11.5 and E12.5 embryos were examined by TUNEL
assay (Figs. 3M, N, P). At E11.5, apoptotic cells were often
detected at the base of the AV cushion, within the interven-
tricular septum, and the myocardium adjacent to the cushion
mesenchyme (Kim et al., 2001). A similar pattern was observed
in mutant hearts, and no significant difference in the number of
TUNEL-positive cardiomyocytes was observed between con-
trol and mutant hearts at E11.5 (Figs. 3M, N). At E12.5, there
was even a decrease of TUNEL-positive cell number of the
whole heart (Fig. 3P). These observations indicate that
decreased cardiomyocyte proliferation, rather than increased
apoptosis leads to poorly developed ventricular wall.
Smad4 mutant embryos showed decreased expression of
contractility markers
To determine whether disruption of Smad4 in cardiomyo-
cytes affects ventricular cell differentiation, we examined the
expression of contractility markers in E12.5 embryos by in situ
hybridization. The early myocardial differentiation marker,
ventricular myosin light chain2 (Mlc2v), was detected in both
ventricular compact myocardium and trabeculae and decreased
in mutant hearts, relative to control hearts (Figs. 4A, B). Another
broadly expressed myocardial differentiation marker, α-cardiacgical analysis of Smad4Co/Co;α-SMA–Cre (A–D) embryos compared to control
l differences were found among E11.5 embryos. Mutant embryos displayed
2.5 and E13.5 (red arrows in panels F and G), and were resorbed by E15.5 (H).
Fig. 3. Histological analysis of Smad4Co/Co;α-SMA–Cre mutant hearts. (A–H) H&E staining of transverse sections of control and Smad4 mutant hearts. (A, B) At
E12.5, Smad4 mutant hearts appeared fragile, with enlarged ventricle lumen, attenuated and disorganized ventricular trabeculations. Note the spongy base of the
ventricular septum indicated by black arrow. (C, D) Higher magnification of areas demarcated in panels A and B revealed that the compact layer of mutant hearts was
much thinner than in that of controls. (E, F) Morphology of endocardial cushion at the outflow tract region showed no difference between E12.5 mutant (F) and control
hearts (E). (G, H) A ventricular septum defect (VSD) (asterisk) was evident in Smad4 mutant heart (H) but not in control heart (G). (I, J) BrdU incorporation in E12.5
control and mutant hearts. The number of proliferating cardiomyocytes in Smad4 mutant hearts was decreased significantly. (K, L) Higher magnification of areas
demarcated in panels I and J. (M, N) TUNEL staining revealed no increase of apoptosis in cardiomyocytes of mutant hearts at E11.5. Small patches of dying cells are
apparent in the myocardium underlying the interventricular septum (arrows). Scale bar represents 200 μm in panels A, B, E, F, I, J; 50 μm in panels C, D, K, L; 800 μm
in panels G, H and 60 μm in panels M, N. (O, P) Quantitative analysis of cardiomyocyte proliferation index at E11.5 and E12.5 of interventricular septum region and
compact zone (O) and apoptosis of whole heart at E11.5 and E12.5 (P). The difference of proliferation rate between E12.5 controls and Smad4mutants was statistically
significant. WT and CKO designate Smad4Co/+;α-SMA–Cre and Smad4Co/Co;α-SMA–Cre genotype, respectively. IVS, interventricular septum.
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4D, E). α-myosin heavy chain (α-MHC) and β-myosin heavy
chain (β-MHC), which are mostly expressed in atrial and
ventricular myocytes, respectively, at this stage, were also
significantly downregulated in Smad4 mutant hearts (Figs. 4G,
H, J, K). The decreased expression of these contractile genes was
also confirmed by quantitative real-time PCR (Figs. 4C, F, I, L)
and RT–PCR (data not shown), indicating that Smad4 is
required for cardiogenic differentiation at mid-gestation.
Altered expression of critical cardiac transcription factors in
Smad4 mutant hearts
To determine the effects of Smad4 deficiency on TGF-β and
BMP signaling in cardiomyocytes, we examined phosphoryla-tion of Smad2 and Smad1/5/8 by immunohistochemistry. At
E11.5, reduced nuclear P-Smad2 staining was detected in
Smad4 mutant interventricular septum (65.9±0.7% in controls
and 45.1±3.6% in Smad4 mutants, n=4 each, Pb0.01, Fig.
5G) and ventricular compact wall cardiomyocytes (46.0% in
controls and 41.7% in Smad4 mutants, n=4 each, Pb0.05, Fig.
5G), compared with that in the controls (Figs. 5A, B and data
not shown). Nuclear P-Smad1/5/8 staining in endothelial cells
that line the developing trabeculae in control and Smad4mutant
hearts was comparable at this stage (Figs. 5C, D). However, the
proportion of P-Smad1/5/8-positive cardiomyocytes located
in the interventricular septum (24.7±5.0% in controls and
47.7±6.4% in Smad4 mutants, n=4 each, Pb0.01) and com-
pact layer (11.3±2.4% in controls and 26.5±7.0% in Smad4
mutants, n=4 each, Pb0.01, Fig. 5H) was significantly higher
Fig. 4. In situ hybridization and real-time PCR analysis of control and mutant hearts at E12.5. Antisense RNA probes for MLC2v (A, B), α-cardiac actin (D, E), α-
MHC (G, H) and β-MHC (J, K). Expression of all these genes was downregulated, but still detectable in the ventricle part of mutant hearts. Scale bar represents
200 μm. (C, F, I, L) Quantitative real-time PCR analysis of MLC2v (C), α-cardiac actin (F), α-MHC (I) and β-MHC (L).
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less organized (Figs. 5E, F).
We also checked the expression of TGF-β2, BMP4 and
BMP10, which are essential for ventricular myocardium
development, by RT–PCR. BMP4 and BMP10 level was
slightly increased, while TGF-β2 transcription was slightly
reduced in Smad4 mutant hearts (Fig. 5H). Elevation of BMP10
expression were further confirmed by real-time PCR (Fig. 5I),
while no significant difference of BMP4 expression was
detected (P=0.29).
We next examined the expression of transcription factors
known to be critical for cardiac development. In situ
hybridization revealed that the expression of the cardiogenic
transcription factor Nkx2.5 and its downstream target atrial
natriuretic factor (ANF) was remarkably decreased in Smad4mutants (Figs. 6B, E), compared with controls (Figs. 6A, D).
The significant downregulation was confirmed by quantitative
real-time PCR (Figs. 6C, F). We also examined expression of
some critical cardiac-specific transcriptional factors GATA4,
MEF2c, and TEF1 by RT–PCR and quantitative real-time PCR.
Expression of GATA4 and MEF2c was downregulated, while
TEF1 expression remained unchanged, in Smad4-deficient
hearts (Figs. 6G–I, and data not shown).
Discussion
Here we provided genetic evidence that Smad4 plays an
essential role in embryonic cardiomyocyte proliferation and
differentiation, and is required to maintain expression of
Nkx2.5, as well as other important cardiogenic transcription
Fig. 5. Altered expression level or activity of TGF-β/BMP family members. (A, B) Immunohistochemical analysis of phosphorylated Smad2 in the ventricular septum
of E11.5 control and Smad4 mutant hearts. (C, D) Immunohistochemical analysis of phosphorylated Smad1/5/8 in the trabecular region of E11.5 control and Smad4
mutant hearts. (E, F) Immunohistochemical analysis of phosphorylated Smad1/5/8 in the ventricular septum of E11.5 control and Smad4 mutant hearts. Scale bar
represents 30 μm in panels A, B, E and F; 40 μm in panels C and D. (G, H) Quantitative analysis of phosphorylated Smad2 and Smad1/5/8 levels in E11.5 ventricular
septum and compact layer cardiomyocyte, n=4 embryos each. (I) RT–PCR analysis of TGFβ-2, BMP4 and BMP10. HPRT serves as internal control. (J) Quantitative
real-time PCR analysis of BMP4 and BMP10. IVS, interventricular septum.
143X. Qi et al. / Developmental Biology 311 (2007) 136–146factors. Previously, we showed that Smad4 is involved in
postnatal cardiac development using an α-MHC–Cre transgenic
strain that expresses high level of Cre recombinase after birth
(Wang et al., 2005). In present study, we used an α-SMA–Cre
transgenic mouse line that directs Cre expression in cardio-
myocytes at E9.5 to produce a cardiac-restricted Smad4
knockout mouse. The normal initiation of cardiac development
and cushion induction in Smad4 mutants was presumably due
to Smad4 expression from floxed alleles prior to Cre-mediated
recombination (Fig. 1A). The importance of Smad4 during
embryonic cardiac development was revealed by defective heart
morphogenesis, including poor trabeculation, a thinner compact
myocardium, and ventricular septum defects, in Smad4mutants.
These data suggested that Smad4 has important but distinct
functions in embryonic and adult hearts.
Proliferation of cardiomyocytes is necessary to support the
increasing hemodynamic load at mid-gestation (Srivastava andOlson, 2000). Importantly, we found that Smad4 is required for
maintaining cardiac growth during embryonic development. We
showed that targeted disruption of Smad4 in cardiomyocytes at
mid-gestation resulted in hypoplastic ventricular walls and
impaired trabeculation due to reduced cell proliferation rather
than increased apoptosis. A large body of evidence suggests that
BMP signaling is essential for maintaining cardiomyocyte
proliferation during murine cardiogenesis. BMP10-deficient
mice exhibit a dramatic reduction in cardiomyocyte prolifera-
tion (Chen et al., 2004), and downregulation of BMP10 is
accompanied by reduced cardiomyocyte proliferation in Nkx2.5
and Notch1 mutants (Pashmforoush et al., 2004; Grego-Bessa
et al., 2007). Conditional loss of ALK3 in the mid-gestation
myocardium leads to multiple cardiac defects involving the
ventricular septum, trabeculae, compact myocardium and
endocardial cushion, due to increased cardiomyocyte apoptosis
and downregulated TGF-β2 expression (Gaussin et al., 2002).
Fig. 6. Down-regulation of essential heart-specific regulatory factors. (A, B, D, E) In situ hybridization of Nkx2.5 and ANF in control and mutant hearts at E12.5.
Expression of Nkx2.5 and ANF decreases significantly. Scale bar represents 200 μm. (C, F–I) Quantitative real-time PCR of Nkx2.5 (C), ANF (F), MEF2c (G),
GATA4 (H) and TEF1 (I) of pooled E12.5 heart cDNA, n=4.
144 X. Qi et al. / Developmental Biology 311 (2007) 136–146Impaired cardiac growth and reduced trabeculation are observed
in Smad5;Smad7 double knockout embryos (Solloway and
Robertson, 1999), while BMP6;BMP7 double knockout
embryos also die between E10.5 and E15.5 due to heart
insufficiency, and display significantly perturbed cell prolifera-
tion without increased apoptosis (Kim et al., 2001). Our data
showed that the phenotypes of the Smad4Co/Co;α-SMA–Cre
mutant embryos largely copied BMP10-deficient embryos
which exhibited a dramatic reduction of cardiomyocyte
proliferation and downregulation of Nkx2.5 and MEF2c,
indicating that the phenotypes in Smad4 mutant hearts at mid-
gestation could be mainly attributed to BMP signaling.
However, we could not completely exclude that Smad4-
mediated TGF-β signals regulate cardiomyocyte proliferation
at mid-gestation, since loss of Smad4 led to reduced TGF-β
signaling, as measured by Smad2 phosphorylation in cardio-
myocytes. Interestingly, we found that P-Smad1/5/8 was
increased in the mutant IVS and compact layer cardiomyocytes,
which was correlated with up-regulation of BMP10. Thissuggested a possible negative feedback mechanism in regulat-
ing BMP signals in cardiomyocytes at mid-gestation.
Embryonic heart development is driven by a number of
evolutionarily conserved transcription factors that determine
cardiac cell fates, control the expression of genes encoding
contractile proteins, and regulate cardiomyocyte proliferation
and differentiation. In this study, we revealed that Smad4 is
required in the cardiac lineage for maintaining the expression
level of cardiogenic transcription factors Nkx2.5, GATA4 and
MEF2c. This is consistent with a previous report that BMP
signaling is sufficient to induce expression of Nkx2.5
(Schultheiss et al., 1997). Moreover, a conserved cluster of
Smad1/4 consensus binding sequences has been identified
within essential regulatory sequences of the Nkx2.5 gene
(Liberatore et al., 2002; Lien et al., 2002). In vivo studies
have also demonstrated that BMP10 is required to maintain
normal expression levels of Nkx2.5 and MEF2c in the
developing myocardium (Chen et al., 2004). In addition,
BMP10 expression is aberrantly increased in ventricular
145X. Qi et al. / Developmental Biology 311 (2007) 136–146Nkx2.5 gene knockout embryos, suggesting that Nkx2.5 acts as
a negative-feedback regulator of BMP10 (Pashmforoush et al.,
2004). In Smad4-deficient hearts, we detected reduced expres-
sion of Nkx2.5 and its downstream target ANF, consistent with
the proposal that Smad4 acts upstream of Nkx2.5 to coordinate
heart development during mid-gestation.
The cardiogenic transcription factors Nkx2.5, GATA4 and
MEF2c, which were downregulated in Smad4 mutants, have
been shown to be required for expression of cardiac contractile
protein genes and cardiac patterning at the early stage of
cardiogenesis (Olson, 2006). Since the deletion of Smad4 was
induced in differentiated cardiomyocytes in Smad4Co/Co;α-
SMA–Cre mutants, embryos displayed normal cardiac pattern-
ing, but impaired terminal differentiation. As mentioned above,
this was correlated with decreased expression of the key
cardiogenic transcription factors Nkx2.5, GATA4 and MEF2c,
suggesting that the downregulation of these cardiac transcrip-
tion factors might contribute to impaired cardiomyocyte
differentiation seen in Smad4 mutants. Our data contradict a
recently published study using a cTnt–Cre transgenic line to
disrupt Smad4 gene in the myocardium at mid-gestation (Song
et al., 2007). Song et al. showed that normal differentiation of
cardiomyocytes and normal expression of Nkx2.5, MEF2c and
GATA4 were exhibited in Smad4 mutants. The discrepancy
may be caused by different Cre transgenic mouse lines used in
these studies. The cTnt–Cre mouse used by Song et al. has
been shown to induce recombination from E7.5, but
effectively inactivate target genes at E10.5 (Jiao et al.,
2003). The α-SMA–Cre line we used in this study efficiently
mediated recombination and inactivated target genes at E9.5
(Figs. 1B and L). Our results suggest that Smad4 might play
distinct roles at different stages during embryonic myocardial
development.
Together, our findings reveal that Smad4 is required for
proper proliferation and differentiation of cardiac myocyte after
initial cell specification and primary differentiation, reinforcing
the importance of TGF-β/BMP signaling and a pivotal role of
Smad4 for embryonic heart growth. Our data also suggest that
Smad4 participate in the complex regulatory mechanism of
mid-gestation cardiomyocyte development, possibly by inter-
acting with multiple heart-specific transcription factors.
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